Exencial Wealth Advisors LLC lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 12.7% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 641 shares of the medical equipment provider’s stock after purchasing an additional 72 shares during the quarter. Exencial Wealth Advisors LLC’s holdings in Intuitive Surgical were worth $335,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also modified their holdings of the company. Berbice Capital Management LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $26,000. BankPlus Trust Department acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $28,000. Kohmann Bosshard Financial Services LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $31,000. MidAtlantic Capital Management Inc. acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at $33,000. Finally, Decker Retirement Planning Inc. acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $36,000. Institutional investors and hedge funds own 83.64% of the company’s stock.
Wall Street Analysts Forecast Growth
ISRG has been the subject of several research analyst reports. Stifel Nicolaus increased their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. Evercore ISI increased their price objective on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Jefferies Financial Group increased their price objective on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Wells Fargo & Company increased their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Finally, Raymond James increased their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. One research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $613.10.
Insider Buying and Selling
In related news, CFO Jamie Samath sold 270 shares of the stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at $4,730,093.55. This represents a 2.99 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 12,598 shares of company stock worth $7,223,467 in the last quarter. 0.90% of the stock is currently owned by company insiders.
Intuitive Surgical Stock Up 1.8 %
NASDAQ:ISRG opened at $568.02 on Thursday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The firm has a market cap of $202.32 billion, a price-to-earnings ratio of 88.61, a P/E/G ratio of 5.85 and a beta of 1.43. The company’s 50 day moving average is $571.70 and its 200-day moving average is $530.90.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
- Five stocks we like better than Intuitive Surgical
- EV Stocks and How to Profit from Them
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- Conference Calls and Individual Investors
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Basic Materials Stocks Investing
- Is Advanced Micro Devices Stock Slide Over?
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.